Merus closing in on cancer Bill Lundberg, MD, MBA CHIEF EXECUTIVE OFFICER Cecile Geuijen, PhD CHIEF SCIENTIFIC OFFICER SPEAKERS Andrew Joe, MD CHIEF MEDICAL OFFICER Kathleen Farren IR/CORP COMMS October 26, 2022 MCLA-129 update EORTC-NCI-AACR Disclaimer 2 This presentation (including any oral commentary that accompanies this presentation) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this presentation that do not r ...